What are the major opportunities in the Sexually Transmitted Infections (STIs) market? What are the strategies for the Sexually Transmitted Infections (STIs) market?

For detailed insights on the major opportunities and strategies in the Sexually Transmitted Infections (STIs) market, Read More

How does the Sexually Transmitted Infections (STIs) market relate to the overall economy and other similar markets?

For detailed insights on Sexually Transmitted Infections (STIs)'s relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Sexually Transmitted Infections (STIs) market growth? SWOT analysis of the Sexually Transmitted Infections (STIs) market.

For detailed insights on the key dynamics influencing the Sexually Transmitted Infections (STIs) market growth and SWOT analysis of the Sexually Transmitted Infections (STIs) industry, Read More

Sexually Transmitted Infections (STIs) Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Sexually Transmitted Infections (STIs) Market Report 2026

Name: Sexually Transmitted Infections (STIs) Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Human Immunodeficiency Virus (HIV), Human Papilloma Virus (HPV), Gonorrhea, Syphilis, Other Types), By Treatment (Antibiotics, Antiviral), By Location Of Testing (Laboratory Testing, Point-Of-Care (POC) Testing), By Route Of Administration (Oral, Parenteral, Other Route Of Administration), By End-Users (Hospitals, Specialty Clinics, Homecare, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Sexually Transmitted Infections (STIs) Market Overview

• Sexually Transmitted Infections (STIs) market size has reached to $71.28 billion in 2025

• Expected to grow to $126.99 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%

• Growth Driver: Government Initiatives Fueling Growth In The Sexually Transmitted Infections (STIS) Market

• Market Trend: Innovative Fluorescent Pcr Technology Advancements By Leading Companies In The Sexually Transmitted Infections (STIS) Market

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Sexually Transmitted Infections (STIs) Market?

Sexually transmitted infections (STIs), also known as sexually transmitted diseases (STDs), refer to diseases caused by viruses, bacteria and parasites that are passed from one person to another through sexual contact. These infections can be transmitted by vaginal, anal and oral sex and through skin-to-skin contact.

The main types of sexually transmitted infections (STIs) are human immunodeficiency virus (HIV), human papillomavirus (HPV); gonorrhea, syphilis and others. Human Immunodeficiency Virus (HIV) is a virus that affects the body's immune system by killing a type of white blood cell that aids in infection resistance. The various treatments are antibiotics and antivirals in various locations of testing such as laboratory testing and point-of-care (POC) testing. The various routes of administration are oral, parenteral and others used in hospitals, specialty clinics, homecare and others.

Sexually Transmitted Infections (STIs) Market Global Report 2026 Market Report bar graph

What Is The Sexually Transmitted Infections (STIs) Market Size and Share 2026?

The sexually transmitted infections (stis) market size has grown rapidly in recent years. It will grow from $71.28 billion in 2025 to $79.48 billion in 2026 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to rising prevalence of STIs, limited access to early diagnostic tools, growing government awareness campaigns, urbanization and lifestyle changes, increasing patient visits to sexual health clinics.

What Is The Sexually Transmitted Infections (STIs) Market Growth Forecast?

The sexually transmitted infections (stis) market size is expected to see rapid growth in the next few years. It will grow to $126.99 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to adoption of advanced molecular diagnostics, growth of at-home STI testing, increasing integration with telemedicine platforms, enhanced funding for STI prevention programs, rise of AI-assisted diagnostic tools. Major trends in the forecast period include development of rapid point-of-care STI testing, increasing use of home-based STI test kits, rise in vaccine development for STIs, growing adoption of combination diagnostic platforms, increasing public awareness campaigns for STI prevention.

Book your 30 minutes free consultation with our research experts

Global Sexually Transmitted Infections (STIs) Market Segmentation

1) By Type: Human Immunodeficiency Virus (HIV), Human Papilloma Virus (HPV), Gonorrhea, Syphilis, Other Types

2) By Treatment: Antibiotics, Antiviral

3) By Location Of Testing: Laboratory Testing, Point-Of-Care (POC) Testing

4) By Route Of Administration: Oral, Parenteral, Other Route Of Administration

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Human Immunodeficiency Virus (HIV): HIV Type 1, HIV Type 2

2) By Human Papilloma Virus (HPV): Low-Risk HPV, High-Risk HPV

3) By Gonorrhea: Uncomplicated Gonorrhea, Complicated Gonorrhea

4) By Syphilis: Primary Syphilis, Secondary Syphilis, Tertiary Syphilis

5) By Other Types: Chlamydia, Herpes Simplex Virus (HSV), Hepatitis B, Hepatitis C, Trichomoniasis

What Is The Driver Of The Sexually Transmitted Infections (STIs) Market?

The surge in government initiatives for spreading awareness of sexually transmitted infections is expected to propel the growth of the sexually transmitted infections (STIs) market going forward. A government initiative is a program or policy implemented to achieve a specific goal and address particular problems. The government offers several initiatives to prevent, control and treat sexually transmitted infections (STIs), such as funds for public education campaigns to raise awareness of STIs, vaccines to prevent certain STIs and free or low-cost screening and testing. For instance, in April 2023, Springfield-Greene County Health, a US-based public health department, announced Disease Intervention Specialist (DIS), a new program and partnership with the Missouri Department of Health and Senior Services (Missouri DHSS) to combat the rising spread of sexually transmitted infections (STIs) in Greene County. The two experts in the DIS program, who will primarily focus on syphilis and HIV, will contact those who test positive for these illnesses, connect them with options for treatment and help identify and get in touch with them to make them aware of the infection. Therefore, the surge in government initiatives will drive the sexually transmitted infections (STIs) industry.

Key Players In The Global Sexually Transmitted Infections (STIs) Market

Major companies operating in the sexually transmitted infections (stis) market are Pfizer Inc., Johnson & Johnson, Roche Holdings AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy's Laboratories, Wockhardt Ltd., Zydus Lifescience Ltd., Glenmark Pharmaceuticals Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Otsuka Pharmaceutical Co. Ltd.

Global Sexually Transmitted Infections (STIs) Market Trends and Insights

Major companies operating in the sexually transmitted infections (STIs) market are developing innovative products with fluorescent PCR technology to gain a competitive advantage in the market. Fluorescent PCR (Polymerase Chain Reaction) technology is a molecular biology technique that detects and quantifies specific DNA sequences in a biological sample. For instance, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based provider of molecular diagnostic solutions, introduced two new polymer chain reaction (PCR) kits, Mycoplasma Hominis Real-Time PCR Kit and Treponema Pallidum Real-Time PCR Kit. These Kits provide a complete PCR solution for early diagnosis of sexually transmitted illnesses, which impact many individuals. The BioPerfectus Mycoplasma Hominis Real-Time PCR Kit is a reagent that uses fluorescent PCR technology to detect Mycoplasma hominis in human male urethral swabs, female cervical or vaginal swabs and urine samples. The BioPerfectus Treponema Pallidum Real-Time PCR Kit is designed to detect treponema pallidum nucleic acid in human serum and plasma.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Sexually Transmitted Infections (STIs) Market?

In February 2023, Caraway Health, a US-based provider of digital healthcare company for Gen Z, partnered with Ash Wellness Inc. for an undisclosed amount. The partnership addresses the surge in sexually transmitted infections (STI) in universities. The collaboration gives Generation Z the tools they require to prioritize sexual well-being on personal terms. Ash Wellness Inc. is a US-based provider of remote diagnostic solutions such as home HIV and STI testing.

Regional Outlook

North America was the largest region in the sexually transmitted infection (STIs) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Sexually Transmitted Infections (STIs) Market?

The sexually transmitted infections (STIs) market consists of revenues earned by entities by providing services such as treatment, testing, awareness programs and diagnosis. The market value includes the value of related goods sold by the service provider or included within the service offering. The sexually transmitted infections (STIs) market also includes the sales of treatments such as testing kits, vaccines and medication. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Sexually Transmitted Infections (STIs) Market Report 2026?

The sexually transmitted infections (stis) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the sexually transmitted infections (stis) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Sexually Transmitted Infections (STIs) Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$79.48 billion
Revenue Forecast In 2035	$126.99 billion
Growth Rate	CAGR of 11.5% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Treatment, Location Of Testing, Route Of Administration, End-Users
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., Johnson & Johnson, Roche Holdings AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy's Laboratories, Wockhardt Ltd., Zydus Lifescience Ltd., Glenmark Pharmaceuticals Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Otsuka Pharmaceutical Co. Ltd.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Sexually Transmitted Infections (STIs) Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Sexually Transmitted Infections (STIs) Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Sexually Transmitted Infections (STIs) Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Sexually Transmitted Infections (STIs) Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Development Of Rapid Point-Of-Care Sti Testing

4.2.2 Increasing Use Of Home-Based Sti Test Kits

4.2.3 Rise In Vaccine Development For Stis

4.2.4 Growing Adoption Of Combination Diagnostic Platforms

4.2.5 Increasing Public Awareness Campaigns For Sti Prevention

5. Sexually Transmitted Infections (STIs) Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Diagnostic Laboratories

5.3 Sexual Health Clinics

5.4 Telemedicine Providers

5.5 Public Health Agencies

6. Sexually Transmitted Infections (STIs) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Sexually Transmitted Infections (STIs) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Sexually Transmitted Infections (STIs) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Sexually Transmitted Infections (STIs) Market Size, Comparisons And Growth Rate Analysis

7.3. Global Sexually Transmitted Infections (STIs) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Sexually Transmitted Infections (STIs) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Sexually Transmitted Infections (STIs) Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Sexually Transmitted Infections (STIs) Market Segmentation

9.1. Global Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Human Immunodeficiency Virus (HIV), Human Papilloma Virus (HPV), Gonorrhea, Syphilis, Other Types

9.2. Global Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antibiotics, Antiviral

9.3. Global Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Laboratory Testing, Point-Of-Care (POC) Testing

9.4. Global Sexually Transmitted Infections (STIs) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Parenteral, Other Route Of Administration

9.5. Global Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Homecare, Other End-Users

9.6. Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Human Immunodeficiency Virus (HIV), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

HIV Type 1, HIV Type 2

9.7. Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Human Papilloma Virus (HPV), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Low-Risk HPV, High-Risk HPV

9.8. Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Gonorrhea, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Uncomplicated Gonorrhea, Complicated Gonorrhea

9.9. Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Syphilis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Primary Syphilis, Secondary Syphilis, Tertiary Syphilis

9.10. Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chlamydia, Herpes Simplex Virus (HSV), Hepatitis B, Hepatitis C, Trichomoniasis

10. Sexually Transmitted Infections (STIs) Market Regional And Country Analysis

10.1. Global Sexually Transmitted Infections (STIs) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Sexually Transmitted Infections (STIs) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Sexually Transmitted Infections (STIs) Market

11.1. Asia-Pacific Sexually Transmitted Infections (STIs) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Sexually Transmitted Infections (STIs) Market

12.1. China Sexually Transmitted Infections (STIs) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Sexually Transmitted Infections (STIs) Market

13.1. India Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Sexually Transmitted Infections (STIs) Market

14.1. Japan Sexually Transmitted Infections (STIs) Market Overview

14.2. Japan Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Sexually Transmitted Infections (STIs) Market

15.1. Australia Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Sexually Transmitted Infections (STIs) Market

16.1. Indonesia Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Sexually Transmitted Infections (STIs) Market

17.1. South Korea Sexually Transmitted Infections (STIs) Market Overview

17.2. South Korea Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Sexually Transmitted Infections (STIs) Market

18.1. Taiwan Sexually Transmitted Infections (STIs) Market Overview

18.2. Taiwan Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Sexually Transmitted Infections (STIs) Market

19.1. South East Asia Sexually Transmitted Infections (STIs) Market Overview

19.2. South East Asia Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Sexually Transmitted Infections (STIs) Market

20.1. Western Europe Sexually Transmitted Infections (STIs) Market Overview

20.2. Western Europe Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Sexually Transmitted Infections (STIs) Market

21.1. UK Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Sexually Transmitted Infections (STIs) Market

22.1. Germany Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Sexually Transmitted Infections (STIs) Market

23.1. France Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Sexually Transmitted Infections (STIs) Market

24.1. Italy Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Sexually Transmitted Infections (STIs) Market

25.1. Spain Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Sexually Transmitted Infections (STIs) Market

26.1. Eastern Europe Sexually Transmitted Infections (STIs) Market Overview

26.2. Eastern Europe Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Sexually Transmitted Infections (STIs) Market

27.1. Russia Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Sexually Transmitted Infections (STIs) Market

28.1. North America Sexually Transmitted Infections (STIs) Market Overview

28.2. North America Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Sexually Transmitted Infections (STIs) Market

29.1. USA Sexually Transmitted Infections (STIs) Market Overview

29.2. USA Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Sexually Transmitted Infections (STIs) Market

30.1. Canada Sexually Transmitted Infections (STIs) Market Overview

30.2. Canada Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Sexually Transmitted Infections (STIs) Market

31.1. South America Sexually Transmitted Infections (STIs) Market Overview

31.2. South America Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Sexually Transmitted Infections (STIs) Market

32.1. Brazil Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Sexually Transmitted Infections (STIs) Market

33.1. Middle East Sexually Transmitted Infections (STIs) Market Overview

33.2. Middle East Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Sexually Transmitted Infections (STIs) Market

34.1. Africa Sexually Transmitted Infections (STIs) Market Overview

34.2. Africa Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Sexually Transmitted Infections (STIs) Market Regulatory and Investment Landscape

36. Sexually Transmitted Infections (STIs) Market Competitive Landscape And Company Profiles

36.1. Sexually Transmitted Infections (STIs) Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Sexually Transmitted Infections (STIs) Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Sexually Transmitted Infections (STIs) Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Roche Holdings AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Sexually Transmitted Infections (STIs) Market Other Major And Innovative Companies

Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd.

38. Global Sexually Transmitted Infections (STIs) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Sexually Transmitted Infections (STIs) Market

40. Sexually Transmitted Infections (STIs) Market High Potential Countries, Segments and Strategies

40.1 Sexually Transmitted Infections (STIs) Market In 2030 - Countries Offering Most New Opportunities

40.2 Sexually Transmitted Infections (STIs) Market In 2030 - Segments Offering Most New Opportunities

40.3 Sexually Transmitted Infections (STIs) Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Sexually Transmitted Infections (STIs) Market, Overview Of Key Products - Product Examples

Table 2: Global Sexually Transmitted Infections (STIs) Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Sexually Transmitted Infections (STIs) Market, Supply Chain Analysis

Table 4: Global Sexually Transmitted Infections (STIs) Market, Major Raw Material Providers

Table 5: Global Sexually Transmitted Infections (STIs) Market, Major Resource Providers

Table 6: Global Sexually Transmitted Infections (STIs) Market, Major Manufacturers (Suppliers)

Table 7: Global Sexually Transmitted Infections (STIs) Market, Major Distributors And Channel Partners

Table 8: Global Sexually Transmitted Infections (STIs) Market, Key Technologies & Future Trends

Table 9: Global Sexually Transmitted Infections (STIs) Market, Major Trends

Table 10: Global Sexually Transmitted Infections (STIs) Market, Major End Users

Table 11: Global Sexually Transmitted Infections (STIs) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Sexually Transmitted Infections (STIs) Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Sexually Transmitted Infections (STIs) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Sexually Transmitted Infections (STIs) Market - TAM, US$ Billion, 2025

Table 15: Global Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Sexually Transmitted Infections (STIs) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Human Immunodeficiency Virus (HIV), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Human Papilloma Virus (HPV), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Gonorrhea, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Syphilis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Sexually Transmitted Infections (STIs) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Global Sexually Transmitted Infections (STIs) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Asia-Pacific, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: China, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: India, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Japan, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Australia, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Indonesia, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South Korea, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Taiwan, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: South East Asia, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Western Europe, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: UK, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Germany, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: France, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Italy, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Spain, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Eastern Europe, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: Russia, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: North America, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: USA, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Canada, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: South America, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Brazil, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Middle East, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Africa, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 99: Global Sexually Transmitted Infections (STIs) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 100: Global Sexually Transmitted Infections (STIs) Market - Company Scoring Matrix

Table 101: Pfizer Inc. Financial Performance

Table 102: Johnson & Johnson Financial Performance

Table 103: Roche Holdings AG Financial Performance

Table 104: Merck & Co Inc. Financial Performance

Table 105: AbbVie Inc. Financial Performance

Table 106: Global Sexually Transmitted Infections (STIs) Market, Competitive Benchmarking (In USD Billions)

Table 107: Global Sexually Transmitted Infections (STIs) Market, Competitive Dashboard

Table 108: Global Sexually Transmitted Infections (STIs) Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 109: Global, Sexually Transmitted Infections (STIs) Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 110: Global, Sexually Transmitted Infections (STIs) Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030

Table 111: Global, Sexually Transmitted Infections (STIs) Market Size Gain ($ Billion), Segmentation By Location Of Testing, 2025 – 2030

List Of Figures

Figure 1: Global Sexually Transmitted Infections (STIs) Market, Overview Of Key Products - Product Examples

Figure 2: Global Sexually Transmitted Infections (STIs) Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Sexually Transmitted Infections (STIs) Market, Supply Chain Analysis

Figure 4: Global Sexually Transmitted Infections (STIs) Market, Major Raw Material Providers

Figure 5: Global Sexually Transmitted Infections (STIs) Market, Major Resource Providers

Figure 6: Global Sexually Transmitted Infections (STIs) Market, Major Manufacturers (Suppliers)

Figure 7: Global Sexually Transmitted Infections (STIs) Market, Major Distributors And Channel Partners

Figure 8: Global Sexually Transmitted Infections (STIs) Market, Key Technologies & Future Trends

Figure 9: Global Sexually Transmitted Infections (STIs) Market, Major Trends

Figure 10: Global Sexually Transmitted Infections (STIs) Market, Major End Users

Figure 11: Global Sexually Transmitted Infections (STIs) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Sexually Transmitted Infections (STIs) Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Sexually Transmitted Infections (STIs) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Sexually Transmitted Infections (STIs) Market - TAM, US$ Billion, 2025

Figure 15: Global Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Sexually Transmitted Infections (STIs) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Human Immunodeficiency Virus (HIV), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Human Papilloma Virus (HPV), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Gonorrhea, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Syphilis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Sexually Transmitted Infections (STIs) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Global Sexually Transmitted Infections (STIs) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Asia-Pacific, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: China, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: India, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Japan, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Australia, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Indonesia, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South Korea, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Taiwan, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: South East Asia, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Western Europe, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: UK, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Germany, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: France, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Italy, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Spain, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Eastern Europe, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: Russia, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: North America, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: USA, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Canada, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: South America, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Brazil, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Middle East, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Africa, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 99: Global Sexually Transmitted Infections (STIs) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 100: Global Sexually Transmitted Infections (STIs) Market - Company Scoring Matrix

Figure 101: Pfizer Inc. Financial Performance

Figure 102: Johnson & Johnson Financial Performance

Figure 103: Roche Holdings AG Financial Performance

Figure 104: Merck & Co Inc. Financial Performance

Figure 105: AbbVie Inc. Financial Performance

Figure 106: Global Sexually Transmitted Infections (STIs) Market, Competitive Benchmarking (In USD Billions)

Figure 107: Global Sexually Transmitted Infections (STIs) Market, Competitive Dashboard

Figure 108: Global Sexually Transmitted Infections (STIs) Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 109: Global, Sexually Transmitted Infections (STIs) Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 110: Global, Sexually Transmitted Infections (STIs) Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030

Figure 111: Global, Sexually Transmitted Infections (STIs) Market Size Gain ($ Billion), Segmentation By Location Of Testing, 2025 – 2030

AL Amyloidosis Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Global Anemia In Elderly Market Trends: Regional Breakdowns and Strategic Insights

Artificial Intelligence (AI) In Aging And Elderly Care Outlook 2034: Key Drivers, Trends, and Market Frontiers

Artificial Intelligence-Powered Solutions For Elderly CareMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

STD Diagnostics Market Report 2026 - Global Outlook – By Type (Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Ch...

Chlamydia Infection Diagnostics Market Report 2026 - Global Outlook – By Test Type (Culture Test, Nucleic Acid Amplification Test (NAAT), Direct Fluorescent Antibody Test, Serology Test, Other Test Types), By Type Of Inf...

Genital Herpes Market Report 2026 - Global Outlook – By Type (Diagnosis, Treatment), By Route Of Administration (Oral, Injectable, Topical), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Other Distribution...

Chlamydia Trachomatis (CT) And Neisseria Gonorrhoeae (NG) Testing Market Report 2026 - Global Outlook – By Test Type (Laboratory, Point Of Care Testing), By Product (Assays And Kits, Instruments Or Analyzers), By Technol...

Chlamydia Infection Diagnostics And Therapeutics Market Report 2026 - Global Outlook – By Type (Nucleic Acid Amplification Tests (NAATS), Direct Fluorescent Tests, Macrolides, Quinolones, Sulfonamides, Tetracycline, Amin...

Chlamydia Infection Treatment Market Report 2026 - Global Outlook – By Treatment (Chlamydia Culture, Urine Culture, Enzyme Immunoassays, Nucleic Acid Amplification Test), By Causative Organisms (Chlamydia Trachomatis, Ch...

Infection Prevention Market Report 2026 - Global Outlook – By Product (Sterilization Equipment, Disinfectors, Consumables), By Infection Type (Microbial Infections, Healthcare Associated Infections), By End User (Hospita...

Frequently Asked Questions

How big is the Sexually Transmitted Infections (STIs) Market?

The Sexually Transmitted Infections (STIs) market was valued at $71.28 billion in 2025, increased to $79.48 billion in 2026, and is projected to reach $126.99 billion by 2030. request a sample here

What is the Sexually Transmitted Infections (STIs) market growth?

The global Sexually Transmitted Infections (STIs) market is expected to grow at a CAGR of 12.4% from 2026 to 2035 to reach $126.99 billion by 2035. request a sample here

Who are the key players in Sexually Transmitted Infections (STIs) market?

Some Key Players in the Sexually Transmitted Infections (STIs) market Include, Pfizer Inc., Johnson & Johnson, Roche Holdings AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy's Laboratories, Wockhardt Ltd., Zydus Lifescience Ltd., Glenmark Pharmaceuticals Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Otsuka Pharmaceutical Co. Ltd. . request a sample here

What is the anticipated growth trend for the Sexually Transmitted Infections (STIs) market?

Major trend in this market includes: Innovative Fluorescent Pcr Technology Advancements By Leading Companies In The Sexually Transmitted Infections (STIS) Market. For further insights on this market. request a sample here

Which region has the most growth potential in the Sexually Transmitted Infections (STIs) market?

North America was the largest region in the sexually transmitted infection (STIs) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sexually transmitted infections (stis) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Who are the key players in the Sexually Transmitted Infections (STIs) Market Report 2026 market?

Major companies operating in the Sexually Transmitted Infections (STIs) Market Report 2026 market are Major companies operating in the sexually transmitted infections (stis) market are Pfizer Inc., Johnson & Johnson, Roche Holdings AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy's Laboratories, Wockhardt Ltd., Zydus Lifescience Ltd., Glenmark Pharmaceuticals Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Otsuka Pharmaceutical Co. Ltd. request a sample here.

Which region has the most growth potential in the Sexually Transmitted Infections (STIs) Market Report 2026 market?